Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Pediatr Hematol Oncol. 2022 Mar 9;39(7):650–657. doi: 10.1080/08880018.2022.2047850

Residence in a Latinx Enclave and End-Induction Minimal Residual Disease Positivity among Children with Acute Lymphoblastic Leukemia

Joshua P Muñiz 1, JP Woodhouse 2,3,4, Amy E Hughes 5, Sandi L Pruitt 5, Karen R Rabin 3,4, Michael E Scheurer 2,3,4, Philip J Lupo 2,3,4, Jeremy M Schraw 2,3,4
PMCID: PMC9458766  NIHMSID: NIHMS1801256  PMID: 35262447

Abstract

Racial and ethnic inequities in survival persist for children with acute lymphoblastic leukemia (ALL). In the US, there are strong associations between SES, race/ethnicity, and place of residence. This is evidenced by ethnic enclaves: neighborhoods with high concentrations of ethnic residents, immigrants, and language isolation. The Latinx enclave index (LEI) can be used to investigate how residence in a Latinx enclave is associated with health outcomes. We studied the association between LEI score and minimal residual disease (MRD) in 142 pediatric ALL patients treated at Texas Children’s Hospital. LEI score was associated with end-induction MRD positivity (OR per unit increase 1.63, CI 1.12–2.46). There was also a significant trend towards increased odds of MRD positivity among children living in areas with the highest enclave index scores. MRD positivity at end of induction is associated with higher incidence of relapse and lower overall survival among children with ALL; future studies are needed to elucidate the exact causes of these findings and to improve ALL outcomes among children residing within Latinx enclaves.

Keywords: ALL, Latinx enclave, MRD, health inequities

Introduction

Acute lymphoblastic leukemia (ALL) remains a leading cause of cancer death in children and adolescents.1,2 ALL is a cancer with well-described ethnic inequities; in particular, Latinx children bear the dual burden of higher incidence and poorer prognosis, relative to other groups.3 Delavar et al3, for example, showed that Latinx pediatric patients had a 1.6-fold increased hazard of death relative to non-Latinx White patients for high-survival cancers such as ALL. It is unclear to what extent these inequities stem from biological factors, social-environmental factors, or a combination of the two, but our group and others have shown an association between low neighborhood socioeconomic status (SES) and worse overall survival (OS) for pediatric ALL patients.214

In the US, there are strong associations between SES, race/ethnicity, and place of residence. This is evidenced by the existence of clear clusters of high/low SES neighborhoods as well as ethnic enclaves: neighborhoods with high concentrations of ethnic residents, immigrants, and language isolation. The Latinx enclave index (LEI), based on factors such as the proportion of residents in a neighborhood who are Latinx, foreign born, and recent immigrants, has been widely used to investigate how residence in a Latinx enclave affects health outcomes.1525 However, no studies have evaluated the effect of residence in a Latinx enclave and outcomes for children with ALL. The primary objective of this study was to determine whether there is an association between residence in a Latinx enclave and end-induction MRD positivity, a strong predictor of relapse and overall survival in childhood ALL.26

Methods

Study Population and Design

This was an IRB-approved, single-center, retrospective study of individuals diagnosed with B-cell ALL at Texas Children’s Hospital between 2007–2018 who were less than 18 years of age at the time of diagnosis (N=142). This population was previously described by our group.12 Notably, it was purposefully enriched for MRD-positive individuals. Patients were enrolled in and treated according to the Children’s Oncology Group (COG) frontline ALL trials as indicated for their disease type and National Cancer Institute (NCI) risk group. Race and ethnicity were self-reported and categorized as non-Latinx White, non-Latinx Black, Latinx, or other Non-Latinx/unknown. The primary study outcome was end-induction MRD status, defined as ≥0.01% leukemic blasts detected in bone marrow by flow cytometry at day 29 of therapy.

Latinx Enclave Designation

Methods for calculating Latinx enclave index scores have previously been described in detail.27 Briefly, we computed LEI scores for each patient by principal components analysis (PCA) of the following U.S. Census and American Community Survey data elements: percent of residents who are Hispanic in the individual’s census tract, percent who are Hispanic and foreign born, percent households that are linguistically isolated, and percent of Spanish language-speaking households that are linguistically isolated. Linguistically isolated households are those in which all members in a household aged ≥14 years speak a non-English language and speak English less than “very well”. Each individual’s transformed LEI score was then assigned to a quartile, based on the distribution of scores for all census tracts in Texas: lowest (LEI-1), lower-middle (LEI-2), higher-middle (LEI-3), and highest (LEI-4). A higher LEI score means that the individual lives in a more ethnically distinct neighborhood (i.e. an “ethnic enclave”).

Statistical Analysis

To assess potential demographic differences by quartile of LEI score, chi-squared tests and Fisher’s exact test were used. We conducted both crude and adjusted logistic regression analysis to estimate the odds ratio (OR) of MRD positivity according to LEI score. The lowest quartile (LEI-1: non-enclave) was used as the referent. All statistical analyses were conducted in R v3.6.0 (R Foundation; Vienna, Austria). For all tests, p-values < 0.05 were considered statistically significant. The following variables were included in adjusted logistic regression analyses: sex (male, female), weight (overweight/obese vs. not), age at diagnosis, unfavorable cytogenetics (defined as BCR-ABL1 fusion, KMT2A rearrangement, hypodiploidy, or intrachromosomal amplification of chromosome 21 [iAMP21] at diagnosis), and NCI risk group (standard, high).

Results

Patient Demographics

Information on the 142 patients included in the analysis are presented in Table 1. A majority of the population was male (58.5%), and 62% of the population identified as Latinx. The proportions of NCI high risk and MRD-positive patients were also high (44.4% and 37.3%, respectively). The distribution of LEI scores skewed toward the higher quartiles. When assessing the demographic differences between MRD-negative and MRD-positive groups, there were no statistically significant differences except by NCI risk category and age at diagnosis (Table 1). NCI high risk status was significantly more frequent in the MRD-positive group (58.5%, p=0.01), and children ≥ 10 years old were also more frequent in the MRD-positive group (43.4%, p=0.02).

TABLE 1.

Patient demographics by MRD status.

MRD negative MRD positive p-value
Sex 0.16
 Female 41 (46.1%) 18 (34.0%)
 Male 48 (53.9%) 35 (66.0%)
Race/ethnicity 0.16
 Latinx 51 (57.3%) 37 (69.8%)
 Non-Latinx White 30 (33.7%) 10 (18.9%)
 Non-Latinx Black or Other 8 (9.0%) 6 (11.3%)
Overweight status 0.26
 Not Overweight/Obese 65 (73.6%) 34 (64.2%)
 Overweight/Obese 21 (23.6%) 17 (32.1%)
 Unknown or NA 3 (3.4%) 2 (3.8%)
NCI risk group 0.01
 Standard 57 (64.0%) 22 (41.5%)
 High 32 (36.0%) 31 (58.5%)
Primary Language 0.31
 English 69 (77.5%) 37 (69.8%)
 Spanish 20 (22.5%) 16 (30.2%)
Cytogenetic category 0.44
 Favorable or neutral 78 (87.6%) 44 (83.0%)
 Unfavorable 11 (12.4%) 9 (17.0%)
Latinx Enclave Index Quartiles 0.18
 LEI-1 (Lowest LEI Scores) 12 (13.5%) 4 (7.5%)
 LEI-2 18 (20.2%) 6 (11.3%)
 LEI-3 27 (30.3%) 15 (28.3%)
 LEI-4 (Highest LEI Scores) 32 (36.0%) 28 (52.8%)
Age at Diagnosis 0.02*
 Infant (<1 year) 0 (0.0%) 1 (1.9%)
 Child (1–9 years) 66 (74.2%) 29 (54.7%)
 Adolescent (≥10 years) 23 (25.8%) 23 (43.4%)

All p-values were obtained with the Chi-Squared test, except for *, which was obtained using the Fisher’s Exact Test.

When evaluating demographics by LEI quartiles, several findings emerged. First, as expected, there were higher proportions of Latinx patients and primary Spanish speakers residing in the two highest LEI quartiles (63.9% and 90.3%, p < 0.001 for Latinx patients; 27.8% and 37.1%, p=0.003 for primary Spanish speakers; see Supplemental Table 1). There were no statistically significant differences in sex, age, NCI risk, cytogenetics, or MRD status according to enclave residence. Of note, there was a statistically significantly greater prevalence of overweight and obesity among patients in the higher LEI quartiles (p=0.03, see Supplemental Table 1). Multiple studies have shown a higher prevalence of obesity in Latinx children compared to their non-Latinx peers, including in Texas.2830

Latinx Enclave Index Score and MRD

Increasing LEI scores, measured continuously, were associated with a statistically significant increased risk of MRD positivity in both the crude (OR 1.30, CI 1.07–1.59) and adjusted (OR 1.63, CI 1.12–2.46) models. There was a statistically significant trend towards increased odds of MRD positivity with increasing quartile of LEI scores in unadjusted and adjusted models (Table 2). While not significant, there was evidence that males were more likely to be MRD-positive (OR 1.61, 95% CI 0.75–3.54), as well as those in the NCI high risk group (OR 3.09, 95% CI 0.98–9.79). Further adjustment for overweight/obesity and age did not meaningfully change the associations between LEI quartile and MRD.

TABLE 2.

Regression analysis of Latinx enclave index scores and MRD positivity.

Crude OR (95% CI) Adjusted OR (95% CI)b
Latinx Quartile p=0.03a p=0.01a
 LEI-1 (Lowest) 1.00 (Ref) 1.00 (Ref)
 LEI-2 1.00 (0.23–4.62) 0.69 (0.14–3.54)
 LEI-3 1.67 (0.48–6.79) 1.55 (0.41–6.68)
 LEI-4 (Highest) 2.62 (0.81–10.24) 2.91 (0.85–11.96)
Male (vs Female) 1.66 (0.83–3.41) 1.61 (0.75–3.54)
High NCI Risk (vs Standard) 2.51 (1.26–5.09) 3.09 (0.98–9.79)
Unfavorable Cytogenetics (vs favorable or neutral) 1.45 (0.55–3.77) 1.13 (0.37–3.27)
a

p-for-trend.

b

Adjusted for sex (male, female), overweight/obesity (not shown), age at diagnosis (not shown), unfavorable cytogenetics (defined as BCR-ABL1 fusion, KMT2A rearrangement, hypodiploidy, or iAMP21 at diagnosis), and NCI risk group (standard, high).

Discussion

As studies continue to show health inequities based on race, ethnicity, and SES, it is critically important to understand the social-environmental correlates of these inequities to improve cancer survival in underserved populations. This report suggests an association between living in a Latinx enclave and MRD positivity. Specifically, LEI score was associated with MRD positivity, and there was a significant trend towards increased odds of MRD positivity among children living in areas with the highest enclave index scores. MRD positivity at end of induction is associated with higher incidence of relapse and lower overall survival among children with ALL26,31; therefore, our findings have important implications for long-term outcomes.

There are several potential explanations for our findings. There was an association with higher LEI quartiles and obesity. There are some studies that suggest an association between obesity and worse ALL outcomes, including MRD.32,33 However, in this study, LEI score was still associated with end-induction MRD after controlling for overweight/obesity. In addition, living in an ethnic enclave may indicate poorer access to care, which could directly impact time to diagnosis, choice of treatment center, or clinical trial participation. Factors such as financial burden, effect of diagnosis/treatment on parent employment status, effect on family income, and lack of social support systems may lead to delays, lapses, or non-adherence to therapy. Moreover, language barriers may lead to poorer communication of the diagnosis, timeline of protocol, and importance of adherence to the treatment plan.23,24 Latinx families may contend with the additional stress and fear that interactions with the healthcare system may lead to legal consequences or deportation, causing delayed presentation or attrition. Finally, the exposures associated with living in an ethnic enclave (e.g. chronic stress, environmental contaminants, etc.) may lead to epigenomic alterations, which could affect prognosis.34

There are several strengths of this study. This patient population comes from one of the most racially, ethnically, and socioeconomically diverse metropolitan areas in the country (Houston, TX). All patients were treated on or according to contemporary Children’s Oncology Group protocols. On the other hand, sample size was limited, so the interaction between neighborhood SES and ethnic enclave scores could not be assessed. This single-center study oversampled MRD-positive patients, so the sample may not be comparable to the general population of children with ALL.12

Racial and ethnic inequities in childhood ALL are well documented, but there is scant literature on the pathways that connect these characteristics to treatment outcomes. Moreover, recent data suggest that racial and ethnic inequities may be increasing despite advances in overall survival.3 Therefore, it is critically important that studies address persistent inequities in childhood cancer outcomes. Our findings suggest that living in a Latinx enclave is associated with MRD positivity, which is a strong predictor of relapse and mortality. It may be important to assess neighborhood social-environmental factors at the time of diagnosis, as some of the deleterious effects of residence in those areas may be amenable to intervention. Possible interventions include increased outreach and engagement by cancer centers with Latinx enclaves. This may help ensure access to adequate resources to successfully navigate treatment, including basic needs screening and provision, and ensuring clear communication with the patient and family in their preferred language. Future work is needed to identify and modify risk factors experienced by patients living in ethnic enclaves, to create better treatment strategies, and to ensure equitable outcomes.

Supplementary Material

Supp 1

Acknowledgements

We wish to acknowledge the patients who inspire our work and continue to motivate us daily.

Funding

This work was supported by a St. Baldrick’s Foundation Research Consortium Grant to PJL and KRR, and by the Cancer Prevention Research Institute of Texas (RP180755 to PJL, RP160771 to MES, RP210075 to JMS). This research was also funded by United States National Institutes of Health (NIH) grant 1R01CA237540 (Principal Investigators: Sandi L. Pruitt and Salma Shariff-Marco) and Baylor College of Medicine (Pediatric Pilot Award to Philip J. Lupo).

Abbreviations:

ALL

Acute lymphoblastic leukemia

SES

Socioeconomic status

MRD

Minimal residual disease

OS

Overall survival

LEI

Latinx enclave index

OR

Odds ratio

CI

Confidence Interval

Footnotes

Conflict of Interest

The authors declare that there is no conflict of interest.

References

  • 1.Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015; 373(16):1541–1552. [DOI] [PubMed] [Google Scholar]
  • 2.Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010; 28(15):2625–2634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Barrington-Trimes JL, Cockburn M, Metayer C, Guaderman WJ, Wiemels J, McKean-Cowden R. Rising rates of acute lymphoblastic leukemia in Hispanic children: trends in incidence from 1992 to 2011. Blood. 2015; 125(19):3033–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Delavar A, Barnes JM, Wang X, Johnson KJ. Associations between race/ethnicity and US childhood and adolescent cancer survival by treatment amenability. JAMA Pediatr. 2020; 174(5):1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wang L, Bhatia S, Gomez SL, Yasui Y. Differential inequality trends over time in survival among US children with acute lymphoblastic leukemia by race/ethnicity, age at diagnosis, and sex. Cancer Epidemiol Biomarkers Prev. 2015; 24(11):1781–1788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Tai EW, Ward KC, Bonaventure A, Siegel DA, Coleman MP. Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: findings from the CONCORD-2 study. Cancer. 2017; 123(Suppl 24):5178–5189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kent EE, Sender LS, Largent JA, Anton-Culver H. Leukemia survival in children, adolescents, and young adults: influence of socioeconomic status and other demographic factors. Cancer Causes Control. 2009; 20(8):1409–1420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Abrahao R, Lichtensztajn DY, Ribeiro RC, et al. Racial/ethnic and socioeconomic disparities in survival among children with acute lymphoblastic leukemia in California, 1988–2011: a population based observational study. Pediatr Blood Cancer. 2015; 62(10):1819–1825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Erdmann F, Feychting M, Mogensen H, Schmiegelow K, Zeeb H. Social inequalities along the childhood cancer continuum: an overview of evidence and a conceptual framework to identify underlying mechanisms and pathways. Front Public Health. 2019; 7:84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Scheurer ME, Lupo PJ, Schuz J, et al. An overview of disparities in childhood cancer: report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatr Hematol Oncol. 2018; 35(2):95–110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bona K, Blonquist TM, Neuberg DS, Silverman LB, Wolfe J. Impact of socioeconomic status on timing of relapse and overall survival for children treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000–2010). Pediatr Blood Cancer. 2016; 63(6):1012–1018. [DOI] [PubMed] [Google Scholar]
  • 12.Schraw JM, Junco JJ, Brown AL, Scheurer ME, Rabin KR, Lupo PJ. Metabolomic Profiling Identifies Pathways Associated with Minimal Residual Disease in Childhood Acute Lymphoblastic Leukaemia. EBioMedicine, vol. 48, 2019, pp. 49–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Schraw JM, Peckham-Gregory EC, Rabin KR, Scheurer ME, Lupo PJ, Oluyomi A. Area deprivation is associated with poorer overall survival in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2020; 67:e28525. [DOI] [PubMed] [Google Scholar]
  • 14.Bona K, Blonquist TM, Neuberg DS, Silverman LB, Wolfe J. Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000–2010). Pediatric Blood & Cancer, 2016; vol. 63, no. 6, pp. 1012–1018. [DOI] [PubMed] [Google Scholar]
  • 15.Durazo EM, Mbassa RS, Albert MA. Ethnic Enclaves and Type II Diabetes: a Focus on Latino/Latinx Americans. Current Cardiovascular Risk Reports, 2016; vol. 10, no. 11. [Google Scholar]
  • 16.Eschbach K, Ostir GV, Patel KV, Markides KS, Goodwin JS. Neighborhood context and mortality among older Mexican Americans: is there a barrio advantage? Am J Public Health. 2004; 94(10):1807–12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Osypuk TL, Diez Roux AV, Hadley C, Kandula NR. Are immigrant enclaves healthy places to live? The Multi-ethnic Study of Atherosclerosis. Soc Sci Med. 2009; 69:110–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Logan JR, Zhang W, Alba RD. Immigrant enclaves and ethnic communities in New York and Los Angeles. Am Sociol Rev. 2002; 67(2):299–322. [Google Scholar]
  • 19.Morales LS, Lara M, Kington RS, Valdez RO. Socioeconomic, cultural, and behavioral factors affecting Latinx health outcomes. J Health Care Poor Underserved. 2002; 13(4):477–503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Finch BK, Vega WA. Acculturation stress, social support, and self-rated health among Latinos in California. J Immigr Health. 2003; 5(3):109–17. [DOI] [PubMed] [Google Scholar]
  • 21.Mulvaney-Day NE, Alegria M, Sribney W. Social cohesion, social support, and health among Latinos in the United States. Soc Sci Med. 2007; 64(2):477–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Viruell-Fuentes E, Morenoff JD, Williams DR, House JS. Contextualizing nativity status, Latino social ties, and ethnic enclaves: an examination of the ‘immigrant social ties hypothesis’. Ethn Health. 2013; 18(6):586–609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Salas-Wright CP, Robles EH, Vaughn MG, Córdova D, Pérez-Figueroa RE. Toward a typology of acculturative stress: results among Latinx immigrants in the United States. Latinx J Behav Sci. 2015; 37(2):223–42. [Google Scholar]
  • 24.Nobari TZ, Wang M-C, Chaparro MP, et al. Immigrant enclaves and obesity in preschool-aged children in Los Angeles County. Soc Sci Med. 2013; 92:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Shariff-Marco S, Gomez SL, Canchola AJ, et al. Nativity, ethnic enclave residence, and breast cancer survival among Latinas: Variations between California and Texas. Cancer, 2020; 126(12), 2849–2858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Borowitz MJ, Devidas M, Hunger SP, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children’s Oncology Group study. Blood, 2008;111(12), 5477–5485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Shariff-Marco S, Lin K, Meltzer D, et al. Developing measures of Asian American and Hispanic/Latino ethnic enclave for five states using U.S. Census and American Community Survey data. University of California San Francisco, San Francisco, CA; October 2021. [Google Scholar]
  • 28.Wang Y Disparities in Pediatric Obesity in the United States. Advances in Nutrition, Volume 2, Issue 1, January 2011, Pages 23–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hoelscher DM, Butte NF, Barlow S, et al. Childhood Obesity. Feb 2015.71–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.“2021 Report: From Crisis to Opportunity.” The State of Childhood Obesity, Robert Wood Johnson Foundation, Oct. 2021, https://stateofchildhoodobesity.org/2021report/. [Google Scholar]
  • 31.Borowitz MJ, Wood BL, Devidas M, et al. Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children’s Oncology Group study AALL0232. Blood, 2015; 126(8), 964–971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Eissa HM, Zhou Y, Panetta JC, et al. The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia. Blood Cancer J. 2017. Feb 17;7(2):e531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Orgel E, Tucci J, Alhushki W, et al. Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemia. Blood. 2014. Dec 18;124(26):3932–8. [DOI] [PubMed] [Google Scholar]
  • 34.Johnstone SE, Baylin SB. Stress and the epigenetic landscape: a link to the pathobiology of human diseases? Nat Rev Genet, 2010. Nov; 11 (11): 806–812. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp 1

RESOURCES